No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
712 |
4. Check minimum number of eventsNone |
712 |
5. Include endpointsNone |
712 |
6. Filter based on genotype QC (FinnGen only) |
712 |
Control definitions (FinnGen only)
- Control exclude
- F5_PERSOBEH
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F60
- Name in latin
- Personalitas paranoides
Similar endpoints
↥List of similar endpoints to
Paranoid personality disorder
based on the number of shared cases.
Similar with more cases:
- Specific personality disorders
- Disorders of adult personality and behaviour
- Any mental disorder
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6839 | 2968 | 3780 |
| Only index persons | 5447 | 2567 | 2880 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.10 | 0.09 | 0.11 |
| Only index persons | 0.10 | 0.09 | 0.11 |
| Median age at first event (years) | |||
| Whole population | 40.20 | 41.73 | 38.84 |
| Only index persons | 38.52 | 39.80 | 37.39 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 712 | 391 | 321 |
| Unadjusted period prevalence (%) | 0.14 | 0.13 | 0.14 |
| Median age at first event (years) | 38.69 | 36.45 | 41.42 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 668
- Matched controls
- 6681
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F60.0
ICD-10 Finland
Paranoid personality disorder
16384.0
323.0
527
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
34.7
245.9
333
186
N05AH03
ATC
olanzapine; systemic
36.1
194.8
256
113
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
501.8
190.1
181
5
N05AH04
ATC
quetiapine; oral
12.9
174.7
374
598
F61.0
ICD-10 Finland
Mixed personality disorders
1072.0
174.3
163
*
N05AX08
ATC
risperidone; systemic
21.2
156.0
243
175
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
1797.9
152.2
142
*
F60.9
ICD-10 Finland
Personality disorder, unspecified
1718.2
146.5
137
*
N05AB03
ATC
perphenazine; systemic, rectal
33.8
136.0
180
72
T36
ICD-10 Finland
Poisoning by systemic antibiotics
28.0
128.3
179
86
F32.9
ICD-10 Finland
Depressive episode, unspecified
10.8
127.5
281
420
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
16.9
125.0
211
177
N05AX12
ATC
aripiprazole; systemic
32.8
122.4
163
65
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
36.0
118.7
154
55
N05AA02
ATC
levomepromazine; systemic
27.6
116.6
163
77
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
21.6
115.2
175
108
F29
ICD-10 Finland
Unspecified nonorganic psychosis
26.1
111.8
159
79
N06AB04
ATC
citalopram; systemic
7.2
105.8
321
757
N05BA04
ATC
oxazepam; oral
6.4
97.0
334
908
N06AX16
ATC
venlafaxine; oral
8.0
95.6
251
466
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
14.3
93.2
167
152
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
20.3
90.9
140
86
N06AB03
ATC
fluoxetine; oral
8.1
89.5
230
407
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
9.8
89.4
198
274
N05BA01
ATC
diazepam; systemic, rectal
8.0
88.8
229
407
N06AB06
ATC
sertraline; oral
8.7
88.0
213
342
N03AG01
ATC
valproic acid; systemic, rectal
13.4
87.5
161
154
30100
ICD-8 Finland
Personality disorders, Paranoid
+∞
87.4
82
*
N05AF03
ATC
chlorprothixene; systemic
32.4
87.3
116
43
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
9.6
84.6
189
263
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
+∞
84.2
79
*
N05CD07
ATC
temazepam; oral
9.0
83.7
196
295
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
9.4
80.8
182
255
N03AX09
ATC
lamotrigine; oral
13.4
75.6
138
127
3010A
ICD-9 Finland
Personality disorders, Paranoid personality disorder
+∞
73.3
69
*
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
32.1
69.3
92
33
N06AX11
ATC
mirtazapine; oral
4.4
67.1
344
1299
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
38.2
66.1
84
25
N05BA06
ATC
lorazepam; systemic, sublingual
13.8
65.5
117
101
F22.0
ICD-10 Finland
Delusional disorder
48.2
63.6
77
18
F34.1
ICD-10 Finland
Dysthymia
15.6
61.1
103
77
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
8.7
60.3
139
195
N05AH02
ATC
clozapine; systemic
31.2
60.0
80
29
P99
ICPC
Psychological disorders other
21.4
59.0
88
47
F60.8
ICD-10 Finland
Other specific personality disorders
312.5
57.2
57
*
P29
ICPC
Psychological sympt/compl other
9.5
57.1
124
156
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
17.9
55.4
88
56
F20.9
ICD-10 Finland
Schizophrenia, unspecified
29.0
55.2
75
29
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
6.6
55.1
156
294
N03AE01
ATC
clonazepam; systemic
9.3
53.7
118
151
N05AD01
ATC
haloperidol; systemic
19.9
53.0
81
46
N06AB05
ATC
paroxetine; oral
8.6
52.0
120
166
N05BE01
ATC
buspirone; oral
17.4
51.8
83
54
N05CF01
ATC
zopiclone; oral
3.7
51.5
304
1217
N05AN01
ATC
lithium; oral
18.5
50.5
79
48
F10.20
ICD-10 Finland
Alcohol dependence currently independent
27.6
47.3
65
26
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
168.2
45.4
47
*
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
30.7
44.3
59
21
N06AB10
ATC
escitalopram; oral
3.7
43.6
234
840
N06AX12
ATC
bupropion; oral
6.8
43.6
118
205
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
15.7
43.3
72
51
N05BA12
ATC
alprazolam; oral
5.5
43.0
140
307
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
19.1
42.9
66
38
N04AA02
ATC
biperiden; systemic
23.0
42.2
61
29
F40.1
ICD-10 Finland
Social phobias
18.8
42.0
65
38
SPAT1240
SPAT
Therapeutic discussion
4.9
41.6
151
373
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
27.0
41.4
57
23
ZY010
NOMESCO Finland
Hospital outpatient
9.0
41.3
91
115
P72
ICPC
Schizophrenia
29.8
41.0
55
20
F61
ICD-10 Finland
Mixed and other personality disorders
218.0
40.3
41
*
N05AC02
ATC
thioridazine; oral
16.6
40.1
65
43
N07BB01
ATC
disulfiram; oral
8.7
40.1
90
117
N06AX03
ATC
mianserin; oral
9.2
39.8
86
105
P76
ICPC
Depressive disorder
6.6
39.5
109
193
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
50.4
39.3
47
10
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
+∞
38.9
37
*
F99
ICD-10 Finland
Mental disorder, not otherwise specified
17.0
38.6
62
40
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
89.6
38.3
42
5
IGY02
NOMESCO Finland
Psychiatric monitoring contact
16.7
37.8
61
40
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
32.9
37.5
49
16
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
15.0
37.4
63
46
F60.1
ICD-10 Finland
Schizoid personality disorder
+∞
36.8
35
*
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
15.5
36.7
61
43
F21
ICD-10 Finland
Schizotypal disorder
72.6
36.4
41
6
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
13.6
35.3
62
50
F31.8
ICD-10 Finland
Other bipolar affective disorders
15.8
35.2
58
40
P01
ICPC
Feeling anxious/nervous/tense
4.3
34.9
143
394
N05AF05
ATC
zuclopenthixol; systemic
34.3
34.9
45
14
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
14.0
34.1
59
46
Z2446
NOMESCO Finland
Social worker
6.4
33.8
94
167
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
21.1
33.1
49
25
F41.1
ICD-10 Finland
Generalized anxiety disorder
6.8
32.9
87
144
F39
ICD-10 Finland
Unspecified mood [affective] disorder
16.3
32.7
53
35
N05AF01
ATC
flupentixol; systemic
20.6
32.2
48
25
N05AA01
ATC
chlorpromazine; systemic, rectal
21.9
32.2
47
23
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
15.0
32.2
54
39
F60.5
ICD-10 Finland
Anankastic personality disorder
41.3
31.5
39
10
F60.2
ICD-10 Finland
Dissocial personality disorder
+∞
31.5
30
*
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
15.7
31.0
51
35
N06CA01
ATC
amitriptyline and psycholeptics; systemic
4.8
30.8
111
267
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
17.0
30.8
49
31
N06AG02
ATC
moclobemide; oral
7.5
30.6
75
111
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
43.5
30.2
37
9
N06AA12
ATC
doxepin; systemic
7.2
30.2
76
117
P80
ICPC
Personality disorder
71.4
30.2
34
5
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
5.9
29.1
85
160
A06AD11
ATC
lactulose; oral
4.0
28.8
126
364
P03
ICPC
Feeling depressed
4.2
28.8
120
332
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
10.3
28.5
57
60
Z2445
NOMESCO Finland
Psychologist
7.6
27.9
67
96
N06AA06
ATC
trimipramine; systemic
13.9
27.9
48
37
N06AX21
ATC
duloxetine; oral
4.0
27.7
122
354
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
6.5
27.7
75
128
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
49.4
27.7
33
7
N06AX05
ATC
trazodone; oral
10.8
27.2
53
53
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
64.9
27.2
31
5
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
12.5
27.1
49
42
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
33.5
27.1
35
11
N03AF01
ATC
carbamazepine; oral, rectal
7.1
27.0
68
105
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
21.7
26.8
39
19
IGY99
NOMESCO Finland
Other psychiatric treatment contact
14.1
26.3
45
34
P74
ICPC
Anxiety disorder/anxiety state
7.7
26.2
62
87
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
8.3
26.1
59
77
N06AB08
ATC
fluvoxamine; oral
10.9
26.0
50
49
F43.1
ICD-10 Finland
Post-traumatic stress disorder
8.7
25.9
57
71
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
18.7
25.6
39
22
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
11.4
25.5
48
45
C07AA05
ATC
propranolol; systemic
2.9
25.4
180
746
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
16.1
25.4
41
27
N06AA09
ATC
amitriptyline; systemic
4.3
25.3
101
267
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
6.2
25.1
70
124
P15
ICPC
Chronic alcohol abuse
9.6
24.7
51
57
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
36.0
24.5
31
9
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.5
24.5
93
234
AA400
NOMESCO Finland
Electroconvulsive therapy
30.5
24.3
32
11
ZY000
NOMESCO Finland
Hospital inpatient
21.7
24.1
35
17
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
13.1
23.9
42
34
F10.24
ICD-10 Finland
Alcohol depence active use
20.4
23.7
35
18
N05AE04
ATC
ziprasidone; systemic
48.6
23.5
28
6
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
37.8
23.2
29
8
N05AL01
ATC
sulpiride; systemic
16.2
23.1
37
24
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
15.6
22.7
37
25
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
12.8
22.6
40
33
L17
ICPC
Foot/toe symptom/complaint
2.6
22.6
195
903
N05CF02
ATC
zolpidem; oral
2.9
22.3
155
628
F41.00
ICD-10 Finland
Moderate panic disorder
12.4
22.3
40
34
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
36.4
22.2
28
8
30041
ICD-8 Finland
Neuroses, Depressiva
30.2
22.0
29
10
Z72.8
ICD-10 Finland
Other problems related to lifestyle
64.8
22.0
25
*
188
Kela drug reimbursment
Psychosis requiring demanding treatment
19.2
21.9
33
18
P06
ICPC
Sleep disturbance
3.7
21.8
103
315
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
118.9
21.7
23
*
A01
ICPC
Pain general/multiple sites
4.7
21.6
76
176
N05BA02
ATC
chlordiazepoxide; systemic
9.7
21.1
43
47
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
216.5
20.7
21
*
2971A
ICD-9 Finland
Paranoid states, Paranoia
113.6
20.7
22
*
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
20.9
20.5
30
15
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
16.7
20.3
32
20
F31
ICD-10 Finland
Bipolar affective disorder
14.3
20.2
34
25
A10BA02
ATC
metformin; oral
2.5
20.2
192
928
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
28.1
20.2
27
10
AA1AD
NOMESCO Finland
CT of head and brain
2.6
20.1
171
776
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.5
20.0
184
872
X78
ICD-10 Finland
Intentional self-harm by sharp object
37.0
20.0
25
7
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
10.3
19.9
39
40
F60.7
ICD-10 Finland
Dependent personality disorder
205.8
19.7
20
*
SPAT1307
SPAT
Psychosocial counselling and guidance
4.2
19.5
78
205
P28
ICPC
Limited function/disability (P)
32.4
19.4
25
8
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
27.0
19.2
26
10
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
18.9
19.2
29
16
ZYC01
NOMESCO Finland
Remote contact by phone
5.6
19.1
57
110
N03AX16
ATC
pregabalin; oral
2.5
19.0
177
844
N05AB01
ATC
dixyrazine; systemic
18.2
18.4
28
16
P98
ICPC
Psychosis NOS/other
45.4
18.3
22
5
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
22.5
18.3
26
12
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.0
18.2
118
450
N06AA04
ATC
clomipramine; systemic
11.1
18.1
34
32
D01
ICPC
Abdominal pain/cramps general
3.3
18.1
99
335
N05AD03
ATC
melperone; systemic
17.1
18.0
28
17
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
12.4
18.0
32
27
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
5.1
17.7
57
120
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
97.7
17.6
19
*
F50.9
ICD-10 Finland
Eating disorder, unspecified
13.6
17.6
30
23
30300
ICD-8 Finland
Alcoholism, Episodic excessive drinking
29.7
17.5
23
8
F20.0
ICD-10 Finland
Paranoid schizophrenia
24.8
17.4
24
10
SPAT1260
SPAT
Consultation of another employee
2.6
17.4
139
605
P18
ICPC
Medication abuse
32.4
17.1
22
7
F41.09
ICD-10 Finland
UNS Panic Syndrome
6.1
17.1
47
82
T90
ICPC
Diabetes non-insulin dependent
2.5
16.9
155
725
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.5
16.9
153
713
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
+∞
16.7
16
*
Z3231
NOMESCO Finland
Registered nurse
2.3
16.7
197
1046
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.3
16.7
64
162
R53
ICD-10 Finland
Malaise and fatigue
2.5
16.7
156
737
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
16.8
16.7
26
16
29830
ICD-8 Finland
Other psychoses, Acute paranoid reaction
92.4
16.6
18
*
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
28.4
16.6
22
8
SPAT1234
SPAT
Support of social functional capacity
4.9
16.5
55
121
F10.09
ICD-10 Finland
Alcohol intoxication UNS
7.9
16.3
37
49
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.6
16.3
58
136
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
30.9
16.2
21
7
103
Kela drug reimbursment
Diabetes, insulin-treated
2.3
16.0
173
877
OAB43
SPAT
NA
0.2
15.9
24
899
H03AA01
ATC
levothyroxine sodium; systemic
2.4
15.9
161
792
S22
ICPC
Nail symptom/complaint
4.5
15.9
57
135
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
15.8
191
1021
F41.8
ICD-10 Finland
Other specified anxiety disorders
6.7
15.7
40
63
F10.25
ICD-10 Finland
Alcohol dependence continuous use
11.2
15.6
29
27
A04
ICPC
Weakness/tiredness general
2.8
15.6
107
422
2961E
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]
163.7
15.5
16
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
15.5
256
1564
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
10.1
15.3
30
31
N05BA05
ATC
potassium clorazepate; oral
29.4
15.3
20
7
30180
ICD-8 Finland
Personality disorders, Immatura
46.1
15.1
18
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.0
15.1
61
162
SPAT1254
SPAT
Administration of medicine
2.7
15.1
111
457
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
8.6
14.9
32
39
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
32.5
14.9
19
6
F20.5
ICD-10 Finland
Residual schizophrenia
32.5
14.9
19
6
X84
ICD-10 Finland
Intentional self-harm by unspecified means
58.0
14.8
17
*
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
5.2
14.6
45
91
A28
ICPC
Limited function/disability NOS
2.9
14.6
92
345
2961C
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
36.9
14.5
18
5
EBA00
NOMESCO Finland
Extraction of tooth
2.0
14.5
240
1457
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.8
14.4
101
404
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
17.5
14.4
22
13
F90.0
ICD-10 Finland
Disturbance of activity and attention
6.5
14.3
37
60
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
7.9
14.3
32
42
G40.9
ICD-10 Finland
Epilepsy, unspecified
6.0
14.3
39
68
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
14.2
154
779
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
5.9
14.0
39
70
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
30.8
13.9
18
6
S04
ICPC
Lump/swelling localized
3.2
13.9
77
261
N05CD02
ATC
nitrazepam; oral
11.8
13.9
25
22
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
5.6
13.8
40
75
B18.2
ICD-10 Finland
Chronic viral hepatitis C
14.0
13.8
23
17
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.2
13.8
157
808
-50
ICPC
Medication/prescr/renewal
5.3
13.8
42
84
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
76.7
13.6
15
*
30188
ICD-8 Finland
Personality disorders, Alia definita
+∞
13.6
13
*
F25.11
ICD-10 Finland
Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms
+∞
13.6
13
*
F25.1
ICD-10 Finland
Schizoaffective disorder, depressive type
+∞
13.6
13
*
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
142.8
13.5
14
*
F25.21
ICD-10 Finland
Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms
142.8
13.5
14
*
IBB03
NOMESCO Finland
Assessment of vocational rehabilitation needs in a mental health context
142.8
13.5
14
*
P19
ICPC
Drug abuse
18.7
13.4
20
11
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
26.4
13.4
18
7
E9509
ICD-8 Finland
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
21.7
13.4
19
9
R06.0
ICD-10 Finland
Dyspnoea
2.2
13.4
164
873
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
10.0
13.3
26
27
D12
ICPC
Constipation
5.8
13.2
37
67
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
6.0
13.2
36
63
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
15.4
13.2
21
14
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
10.3
13.1
25
25
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
29.0
13.0
17
6
F32.1
ICD-10 Finland
Moderate depressive episode
3.8
13.0
56
158
2961D
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]
23.1
12.9
18
8
IGV01
NOMESCO Finland
Psychiatric network contact
23.1
12.9
18
8
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
23.1
12.9
18
8
D06
ICPC
Abdominal pain localized other
3.1
12.9
72
247
N03AX11
ATC
topiramate; oral
6.2
12.9
34
57
K59.09
ICD-10 Finland
Constipation, unspecified
3.9
12.6
52
141
N05AC01
ATC
periciazine; systemic
71.3
12.6
14
*
3017A
ICD-9 Finland
Personality disorders, Antisocial personality disorder
+∞
12.5
12
*
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
24.9
12.5
17
7
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
13.5
12.5
21
16
2988A
ICD-9 Finland
Other nonorganic psychoses, Other and unspecified reactive psychosis
132.4
12.5
13
*
N03AX12
ATC
gabapentin; oral
2.4
12.4
112
513
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.9
12.4
51
138
F32.8
ICD-10 Finland
Other depressive episodes
8.2
12.4
27
34
F51.0
ICD-10 Finland
Nonorganic insomnia
2.5
12.4
109
492
L12
ICPC
Hand/finger symptom/complaint
2.5
12.4
107
481
P16
ICPC
Acute alcohol abuse
9.2
12.3
25
28
L03
ICPC
Low back symptom/complaint
2.1
12.3
171
959
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.9
12.2
213
1301
N06AX18
ATC
reboxetine; oral
10.3
12.1
23
23
F50.2
ICD-10 Finland
Bulimia nervosa
21.8
12.1
17
8
F43.00
ICD-10 Finland
Acute stress reaction mild
5.5
12.0
35
67
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.7
11.9
83
328
T83
ICPC
Overweight
7.6
11.8
27
37
K59.0
ICD-10 Finland
Constipation
4.0
11.8
47
124
S10
ICPC
Boil/carbuncle
3.8
11.7
49
135
29580
ICD-8 Finland
Schizophrenia, Other
30.6
11.7
15
5
30088
ICD-8 Finland
Neuroses, Other
30.6
11.7
15
5
2953E
ICD-9 Finland
Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]
30.6
11.7
15
5
T74.1
ICD-10 Finland
Physical abuse
6.7
11.7
29
45
F63.0
ICD-10 Finland
Pathological gambling
66.1
11.6
13
*
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
66.1
11.6
13
*
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
19.3
11.6
17
9
IER01
NOMESCO Finland
Psychoeducation, group
23.4
11.6
16
7
F61.1
ICD-10 Finland
Disturbing personality change
+∞
11.5
11
*
RT150
NOMESCO Finland
NA
122.0
11.5
12
*
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
122.0
11.5
12
*
A99
ICPC
Disease/condition unspecnature/site
3.1
11.4
65
227
X59
ICD-10 Finland
Exposure to unspecified factor
2.1
11.4
143
762
Z3226
NOMESCO Finland
Physiotherapist
2.2
11.4
127
643
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.7
11.3
80
320
N06AX22
ATC
agomelatine; oral
6.1
11.3
30
51
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
35.7
11.3
14
*
F20
ICD-10 Finland
Schizophrenia
35.7
11.3
14
*
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
17.4
11.2
17
10
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.9
11.2
69
254
30000
ICD-8 Finland
Neuroses, Anxiety neurosis
13.0
11.2
19
15
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.5
11.2
89
382
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.4
11.1
99
451
SPAT1301
SPAT
No procedures
1.9
11.0
209
1306
M54.5
ICD-10 Finland
Low back pain
1.8
11.0
226
1449
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
14.2
11.0
18
13
R96
ICPC
Asthma
2.8
11.0
71
269
RT250
NOMESCO Finland
NA
44.1
10.9
13
*
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
15.8
10.9
17
11
F93.89
ICD-10 Finland
Other childhood emotional disorders
15.8
10.9
17
11
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
15.8
10.9
17
11
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
10.8
275
1892
29999
ICD-8 Finland
Unspecified psychosis
28.5
10.8
14
5
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
21.9
10.7
15
7
IGY02
SPAT
NA
21.9
10.7
15
7
F23.3
ICD-10 Finland
Other acute predominantly delusional psychotic disorders
21.9
10.7
15
7
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
61.0
10.7
12
*
F23.90
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
61.0
10.7
12
*
3000A
ICD-9 Finland
Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]
61.0
10.7
12
*
IEY21
NOMESCO Finland
Other intensified psychiatric treatment
61.0
10.7
12
*
F28
ICD-10 Finland
Other nonorganic psychotic disorders
61.0
10.7
12
*
N06AX17
ATC
milnacipran; oral
9.4
10.6
21
23
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
10.3
10.6
20
20
D09
ICPC
Nausea
3.8
10.5
44
122
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
10.5
104
498
F19.9
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder
111.7
10.4
11
*
F33.31
ICD-10 Finland
Recurrent depression, severe episode of somatic syndrome
+∞
10.4
10
*
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.5
10.4
87
383
IEY01
NOMESCO Finland
Psychoeducation, individual
16.3
10.4
16
10
X61
ICD-10 Finland
Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified
33.1
10.4
13
*
L28
ICPC
Limited function/disability (L)
2.4
10.3
94
432
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
9.8
10.3
20
21
N06AA22
ATC
NA
19.1
10.3
15
8
Z03
ICPC
Housing/neighbourhood problem
23.8
10.3
14
6
H01
ICPC
Ear pain/earache
2.5
10.1
79
334
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
10.1
184
1130
R4140
NOMESCO Finland
Psychotherapy
14.9
10.0
16
11
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
10.0
120
626
29599
ICD-8 Finland
Schizophrenia, Unspecified type
40.7
10.0
12
*
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.2
10.0
37
92
A29
ICPC
General symptom/complaint other
2.6
10.0
78
329
RS220
NOMESCO Finland
NA
7.8
10.0
22
29
WX110
NOMESCO Finland
Local anesthesy
1.7
10.0
456
3699
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
10.0
149
851
S21
ICPC
Skin texture symptom/complaint
2.4
9.9
84
372
Z2221
NOMESCO Finland
Medical doctor
1.9
9.9
182
1117
F33.8
ICD-10 Finland
Other recurrent depressive disorders
12.4
9.9
17
14
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
9.9
325
2396
3004A
ICD-9 Finland
Neurotic disorders, Neurotic depression
26.5
9.8
13
5
309
Kela drug reimbursment
Nalmefene and naltrexone
26.5
9.8
13
5
F40.00
ICD-10 Finland
Agoraphobia without concomitant panic disorder
26.5
9.8
13
5
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
20.4
9.8
14
7
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.8
9.7
203
1300
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.3
9.7
49
158
F32
ICD-10 Finland
Depressive episode
3.0
9.7
55
192
N05AH05
ATC
asenapine; oral
55.8
9.7
11
*
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
55.8
9.7
11
*
F20.01
ICD-10 Finland
Paranoid schizophrenia periodically with gradual deterioration
55.8
9.7
11
*
F25.0
ICD-10 Finland
Schizoaffective disorder, manic type
55.8
9.7
11
*
F25.2
ICD-10 Finland
Schizoaffective disorder, mixed type
55.8
9.7
11
*
V03AA01
ATC
NA
6.5
9.6
24
38
F05.9
ICD-10 Finland
Delirium, unspecified
6.5
9.6
24
38
E66.9
ICD-10 Finland
Obesity, unspecified
4.4
9.6
34
81
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.6
9.6
32
72
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
7.3
9.6
22
31
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.6
9.6
73
305
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
9.5
157
926
R02
ICPC
Shortness of breath/dyspnoea
2.4
9.5
84
382
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
9.5
163
976
-62
ICPC
Administrative procedure
4.9
9.4
30
64
P86
ICPC
Anorexia nervosa/bulimia
17.8
9.4
14
8
ZYD01
NOMESCO Finland
Emergency clinic
30.5
9.4
12
*
SPAT1263
SPAT
Sampling
1.7
9.4
280
1995
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
12.6
9.4
16
13
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
+∞
9.4
9
*
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.3
9.4
47
151
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
22.1
9.4
13
6
N05AE03
ATC
sertindole; oral
22.1
9.4
13
6
T82
ICPC
Obesity
3.9
9.4
38
103
A03CA02
ATC
clidinium and psycholeptics; oral
3.5
9.4
42
124
N01
ICPC
Headache
2.4
9.4
80
355
E66.00
ICD-10 Finland
Metabolic syndrome
3.2
9.3
47
152
P17
ICPC
Tobacco abuse
7.4
9.3
21
29
R03AC02
ATC
salbutamol; inhalant
1.7
9.3
341
2574
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
13.9
9.2
15
11
S06.0
ICD-10 Finland
Concussion
2.4
9.1
76
334
F50.0
ICD-10 Finland
Anorexia nervosa
9.2
9.1
18
20
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
10.2
9.1
17
17
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
10.2
9.1
17
17
N17
ICPC
Vertigo/dizziness
2.5
9.1
71
303
F20.02
ICD-10 Finland
Paranoid schizophrenia stable periodically
37.2
9.0
11
*
R51.80
ICD-10 Finland
Headache
2.1
9.0
107
555
L02
ICPC
Back symptom/complaint
2.5
8.9
70
298
P50
ICPC
Psychological, Medication/prescr/renewal
24.4
8.9
12
5
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.7
8.9
38
108
C03CA01
ATC
furosemide; systemic
1.9
8.8
137
788
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.8
8.8
55
204
TUPKY
NOMESCO Finland
NA
9.7
8.8
17
18
SPAT1241
SPAT
Extensive assessment of psychosocial situation
7.3
8.8
20
28
M79.7
ICD-10 Finland
Fibromyalgia
4.1
8.8
33
84
A27
ICPC
Fear of other disease NOS
4.0
8.8
34
89
N06BA04
ATC
methylphenidate; oral
5.2
8.7
26
52
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
14.3
8.7
14
10
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
50.7
8.7
10
*
2957A
ICD-9 Finland
Schizophrenic psychoses, Schizo-affective type
50.7
8.7
10
*
F19.26
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction
50.7
8.7
10
*
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
50.7
8.7
10
*
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
50.7
8.7
10
*
9691A
ICD-9 Finland
Poisoning by psychotropic agents, Phenothiazine-based tranquillisers
50.7
8.7
10
*
Z29
ICPC
Social problem NOS
5.9
8.7
23
40
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
8.6
122
680
F34.0
ICD-10 Finland
Cyclothymia
11.8
8.6
15
13
Z91.5
ICD-10 Finland
Personal history of self-harm
16.5
8.6
13
8
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.7
8.5
58
228
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.5
8.5
65
274
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
20.3
8.5
12
6
SAA01
NOMESCO Finland
Simple examination of mouth
1.7
8.5
463
3848
2961A
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,TARKEMMIN MÄÄRITTELEMÄTÖN]
91.2
8.4
9
*
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
91.2
8.4
9
*
SAA03
NOMESCO Finland
Extended examination of mouth
1.7
8.4
250
1767
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.7
8.4
58
231
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
13.0
8.4
14
11
F41.01
ICD-10 Finland
Severe panic disorder
13.0
8.4
14
11
R52.2
ICD-10 Finland
Other chronic pain
4.1
8.4
31
78
-69
ICPC
Other reason for encounter NEC
3.8
8.4
34
93
R07.3
ICD-10 Finland
Other chest pain
2.5
8.4
66
282
K04
ICPC
Palpitations/awareness of heart
3.3
8.4
40
125
F13.2
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome
+∞
8.3
8
*
30199
ICD-8 Finland
Personality disorders, Unspecified
+∞
8.3
8
*
F69
ICD-10 Finland
Unspecified disorder of adult personality and behaviour
+∞
8.3
8
*
E66.8
ICD-10 Finland
Other obesity
3.1
8.3
44
148
N03AF02
ATC
oxcarbazepine; oral
4.3
8.3
29
69
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
14.7
8.2
13
9
F50.3
ICD-10 Finland
Atypical bulimia nervosa
14.7
8.2
13
9
N06AX26
ATC
vortioxetine; oral
2.9
8.2
51
188
N05BB01
ATC
hydroxyzine; systemic
2.8
8.2
52
197
D20
ICPC
Mouth/tongue/lip symptom/complaint
3.5
8.1
36
106
Z08
ICPC
Social welfare problem
7.0
8.1
19
28
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
11.9
8.1
14
12
3041A
ICD-9 Finland
Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence
33.8
8.1
10
*
SPAT1262
SPAT
Handing over of treatment supplies
2.0
8.0
110
603
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
22.3
8.0
11
5
F30.9
ICD-10 Finland
Manic episode, unspecified
22.3
8.0
11
5
WX892
NOMESCO Finland
Monitored bed care
2.8
8.0
51
193
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
8.0
86
427
SPAT1310
SPAT
Counselling related to known health issue
1.7
8.0
199
1334
K85
ICPC
Elevated blood pressure
2.2
7.9
81
393
P27
ICPC
Fear of mental disorder
7.9
7.9
17
22
F50.1
ICD-10 Finland
Atypical anorexia nervosa
13.2
7.9
13
10
F45.0
ICD-10 Finland
Somatization disorder
13.2
7.9
13
10
S18
ICPC
Laceration/cut
1.6
7.9
245
1743
R11
ICD-10 Finland
Nausea and vomiting
2.6
7.9
57
232
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
5.8
7.9
21
37
-31
ICPC
Medical examin/health eval partial
2.6
7.9
55
221
SPAT1243
SPAT
Psychiatric/psychological examination
3.8
7.9
32
88
S51.9
ICD-10 Finland
Open wound of forearm, part unspecified
8.6
7.8
16
19
D11
ICPC
Diarrhoea
2.2
7.8
83
411
SPAT1265
SPAT
Breathalyser
11.0
7.8
14
13
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.6
7.8
34
99
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
45.5
7.7
9
*
9690A
ICD-9 Finland
Poisoning by psychotropic agents, Antidepressants
45.5
7.7
9
*
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
45.5
7.7
9
*
P77
ICPC
Suicide/suicide attempt
45.5
7.7
9
*
L29
ICPC
Musculoskeletal sympt/complt other
2.6
7.6
53
212
Z28
ICPC
Limited function/disability (Z)
18.6
7.6
11
6
F20.8
ICD-10 Finland
Other schizophrenia
18.6
7.6
11
6
Z72.2
ICD-10 Finland
Drug use
18.6
7.6
11
6
P73
ICPC
Affective psychosis
12.0
7.6
13
11
F50.8
ICD-10 Finland
Other eating disorders
25.3
7.6
10
*
29530
ICD-8 Finland
Schizophrenia, Paranoid type
25.3
7.6
10
*
F25
ICD-10 Finland
Schizoaffective disorders
25.3
7.6
10
*
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
7.6
253
1831
K02.1
ICD-10 Finland
Caries of dentine
1.6
7.6
377
3014
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
7.5
115
656
G47.9
ICD-10 Finland
Sleep disorder, unspecified
4.9
7.5
23
48
S29
ICPC
Skin symptom/complaint other
2.0
7.5
100
542
WX290
NOMESCO Finland
Other blockade of nerve
1.6
7.4
299
2264
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
7.4
169
1099
RS140
NOMESCO Finland
NA
81.0
7.4
8
*
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
81.0
7.4
8
*
ZXY57
NOMESCO Finland
2-person team, nurse-social worker
81.0
7.4
8
*
30040
ICD-8 Finland
Neuroses, Neurotico-depressiva
13.5
7.4
12
9
N05AX13
ATC
paliperidone; systemic
13.5
7.4
12
9
Z50.7
ICD-10 Finland
Occupational therapy and vocational rehabilitation, not elsewhere classified
13.5
7.4
12
9
30310
ICD-8 Finland
Alcoholism, Habitual excessive drinking
13.5
7.4
12
9
A92
ICPC
Allergy/allergic reaction NOS
4.1
7.3
27
68
T42.4
ICD-10 Finland
Poisoning: Benzodiazepines
+∞
7.3
7
*
29700
ICD-8 Finland
Paranoid states, Paranoia
+∞
7.3
7
*
F31.21
ICD-10 Finland
Bipolar disorder, manic episode with mood incongruent psychotic symptoms
+∞
7.3
7
*
30170
ICD-8 Finland
Personality disorders, Antisocial
+∞
7.3
7
*
V628A
ICD-9 Finland
Other psychosocial circumstances, Other psychological or physical stress, not elsewhere classified
+∞
7.3
7
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
7.3
95
510
N30.0
ICD-10 Finland
Acute cystitis
2.1
7.3
85
436
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
7.3
202
1389
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
3.0
7.3
41
142
E86
ICD-10 Finland
Volume depletion
4.7
7.3
23
50
X58
ICD-10 Finland
Exposure to other specified factors
2.0
7.2
99
544
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.4
7.2
33
101
RS210
NOMESCO Finland
NA
20.3
7.1
10
5
N05AE05
ATC
lurasidone; oral
20.3
7.1
10
5
F34.9
ICD-10 Finland
Persistent mood [affective] disorder, unspecified
20.3
7.1
10
5
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
20.3
7.1
10
5
R63.0
ICD-10 Finland
Anorexia
20.3
7.1
10
5
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
20.3
7.1
10
5
R03BB04
ATC
tiotropium bromide; inhalant
2.3
7.1
62
280
R21
ICPC
Throat symptom/complaint
1.8
7.1
141
880
Z63.0
ICD-10 Finland
Problems in relationship with spouse or partner
10.2
7.1
13
13
SPAT1252
SPAT
Overall medication plan or its review
2.7
7.1
46
178
A02BC01
ATC
omeprazole; systemic
1.7
7.0
164
1074
Z3229
NOMESCO Finland
Other healthcare associate professional
2.5
7.0
55
235
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.2
7.0
35
114
U02
ICPC
Urinary frequency/urgency
2.2
7.0
73
359
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.7
7.0
149
947
C07AB07
ATC
bisoprolol; oral
1.6
7.0
245
1786
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
7.0
132
807
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
7.0
89
474
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.0
7.0
87
459
L15
ICPC
Knee symptom/complaint
1.8
7.0
116
682
SPAT1216
SPAT
Assessment of functional ability
2.0
7.0
85
445
R55
ICD-10 Finland
Syncope and collapse
2.2
7.0
66
311
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.9
6.9
100
559
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
14.0
6.9
11
8
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.2
6.9
34
110
Z00.0
ICD-10 Finland
General medical examination
1.8
6.9
115
677
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.8
6.9
42
157
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
8.4
6.9
14
17
SPAT1100
SPAT
Long-term monitoring of blood pressure
3.1
6.8
36
122
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
6.8
60
273
A46
ICD-10 Finland
Erysipelas
2.1
6.8
80
413
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
11.1
6.8
12
11
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
6.8
243
1778
P58
ICPC
Psychological, Therapeutic counselling/listening
5.8
6.8
18
32
F41.0
ICD-10 Finland
Panic disorder [episodic paroxysmal anxiety]
4.4
6.8
23
54
F19.30
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated
40.5
6.8
8
*
IDR03
NOMESCO Finland
Systematic group therapy, dialectical behaviour therapy (DBT)
40.5
6.8
8
*
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
40.5
6.8
8
*
Z04.0
ICD-10 Finland
Blood-alcohol and blood-drug test
40.5
6.8
8
*
F20.03
ICD-10 Finland
Paranoid schizophrenia periodically with gradual improvement
40.5
6.8
8
*
N05AX16
ATC
brexpiprazole; oral
40.5
6.8
8
*
ICB03
SPAT
NA
40.5
6.8
8
*
F19.2
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome
40.5
6.8
8
*
IEY06
NOMESCO Finland
Psychiatric treatment and rehabilitation coaching
40.5
6.8
8
*
W19
ICD-10 Finland
Unspecified fall
2.3
6.8
62
288
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
3.0
6.7
38
132
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
22.8
6.7
9
*
3090A
ICD-9 Finland
Adjustment reaction, Brief depressive reaction
22.8
6.7
9
*
F40.8
ICD-10 Finland
Other phobic anxiety disorders
22.8
6.7
9
*
R52.9
ICD-10 Finland
Pain, unspecified
2.3
6.6
60
275
M79.1
ICD-10 Finland
Myalgia
2.0
6.6
90
493
30320
ICD-8 Finland
Alcoholism, Alcoholic addiction
12.4
6.6
11
9
U07
ICPC
Urine symptom/complaint other
2.8
6.6
42
159
E66.01
ICD-10 Finland
Obesity due to excess calories
2.2
6.6
63
298
F29
ICPC
Eye symptom/complaint other
2.4
6.6
55
243
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
2.6
6.6
46
185
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
8.8
6.6
13
15
T07
ICPC
Weight gain
8.8
6.6
13
15
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.5
6.6
42
846
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
6.9
6.5
15
22
S00.0
ICD-10 Finland
Superficial injury of scalp
5.1
6.5
19
38
R20.2
ICD-10 Finland
Paraesthesia of skin
2.5
6.5
50
213
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
3.3
6.5
31
98
M79.6
ICD-10 Finland
Pain in limb
1.6
6.5
215
1539
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
6.5
115
688
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.8
6.4
39
145
IAA02
SPAT
NA
70.5
6.4
7
*
F44.88
ICD-10 Finland
Other definite dissociation disorder
70.5
6.4
7
*
3049X
ICD-9 Finland
Drug dependence, Unspecified drug dependence
70.5
6.4
7
*
F10.50
ICD-10 Finland
Alcohol-related psychosis is schizophrenic
70.5
6.4
7
*
31099
ICD-8 Finland
Borderline mental retardation, Other and unspecified
70.5
6.4
7
*
U04
ICPC
Incontinence urine
3.4
6.4
29
88
A60
ICPC
General and Unspecified, Result test/procedure
3.2
6.4
31
99
UKC02
NOMESCO Finland
Cystoscopy
1.9
6.4
87
477
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.1
6.4
33
111
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.5
6.4
49
209
-45
ICPC
Observ/health educat/advice/diet
3.6
6.4
27
78
A02BA02
ATC
ranitidine; systemic
1.8
6.4
114
685
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
0.3
6.4
14
436
R05
ICPC
Cough
1.7
6.3
137
873
SPAT1235
SPAT
Mental health, emotional support
11.2
6.3
11
10
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
3.3
6.3
30
95
IBA03
NOMESCO Finland
Psychotherapy evaluation
9.4
6.3
12
13
F05.8
ICD-10 Finland
Other delirium
18.2
6.3
9
5
SPAT1058
SPAT
PEF monitoring instruction
2.3
6.3
56
257
L18
ICPC
Muscle pain
3.3
6.3
29
90
F60.4
ICD-10 Finland
Histrionic personality disorder
+∞
6.3
6
*
30120
ICD-8 Finland
Personality disorders, Schizoid
+∞
6.3
6
*
F13.9
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, unspecified mental and behavioural disorder
+∞
6.3
6
*
T43.9
ICD-10 Finland
Poisoning: Psychotropic drug, unspecified
+∞
6.3
6
*
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.7
6.2
41
160
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
26.9
6.2
8
*
97010
ICD-8 Finland
Adverse effect of psychotherapeutics, Tranquillisers
26.9
6.2
8
*
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
26.9
6.2
8
*
IEV99
NOMESCO Finland
Other psychiatric network intervention
26.9
6.2
8
*
30799
ICD-8 Finland
Transient situational disturbances
26.9
6.2
8
*
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
26.9
6.2
8
*
IHZ07
SPAT
NA
26.9
6.2
8
*
-1
NOMESCO Finland
NA
1.6
6.2
216
1563
SPAT1057
SPAT
Peak expiratory flow measurement
4.5
6.2
20
45
L84
ICPC
Back syndrome without radiat pain
2.9
6.2
36
130
F41.3
ICD-10 Finland
Other mixed anxiety disorders
5.4
6.2
17
32
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.5
6.2
347
2795
A10BH01
ATC
sitagliptin; oral
2.3
6.2
55
251
R60.9
ICD-10 Finland
Oedema, unspecified
3.1
6.2
32
108
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
7.8
6.1
13
17
SPAT1104
SPAT
Monitoring of emergency patient
2.5
6.1
47
200
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
12.7
6.1
10
8
F45.9
ICD-10 Finland
Somatoform disorder, unspecified
12.7
6.1
10
8
P48
ICPC
Psychological, Clarification/discussion RFE/demand
12.7
6.1
10
8
Z71.8
ICD-10 Finland
Other specified counselling
1.7
6.1
151
1001
L86
ICPC
Back syndrome with radiating pain
2.7
6.1
39
149
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
6.8
6.1
14
21
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.0
6.1
80
432
A97
ICPC
No disease
1.9
6.1
91
515
Y34
ICD-10 Finland
Unspecified event, undetermined intent
10.1
6.0
11
11
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
2.2
6.0
59
281
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3009466) Valproate [Moles/volume] in Serum or Plasma
87
63
15.59
96.23
6.4
5.2
umol/l
379.3
355.8
0.55
71
57
(3028707) Methadone [Presence] in Urine by Screen method
100
101
11.36
89.92
5.1
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
106
175
6.94
63.33
6.9
1.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
232
811
3.76
55.59
2.7
1.7
%
1.6
1.4
2.88
202
724
(1001926) Buprenorphine [Presence] in Urine by Screen method
105
208
5.75
51.85
5.9
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
113
253
5.12
48.54
5.8
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
113
272
4.75
44.36
5.9
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
113
272
4.75
44.36
4.0
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
113
274
4.71
43.94
5.6
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
112
273
4.68
43.25
6.0
1.3
—
—
—
0
0
(4198724)
32
20
16.71
37.67
8.1
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
200
811
3.04
35.74
2.1
1.6
nmol/l
1189.8
1171.6
0.11
159
642
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
346
1919
2.56
32.98
3.8
3.3
u/l
32.8
32.3
0.07
327
1835
(3009508) Creatinine [Moles/volume] in Urine
295
1573
2.49
29.88
4.7
3.0
mmol/l
7.4
8.2
1.77
249
1337
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
343
1981
2.41
28.84
2.0
1.8
pmol/l
95.4
95.4
0.00
197
1070
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
362
2152
2.39
28.36
6.0
6.2
mmol/l
1.2
1.2
0.05
339
1967
(44816559) Phosphatidylethanol [Mass/volume] in Blood
62
132
5.05
27.87
1.3
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
389
2404
2.36
27.63
6.9
6.9
mmol/l
1.2
1.2
0.11
341
2041
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
33
38
9.06
26.47
8.2
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
294
1669
2.30
24.76
3.5
2.6
u/l
49.4
56.1
3.83
268
1557
(3015377) Calcium [Moles/volume] in Serum or Plasma
288
1656
2.24
23.17
2.5
3.3
mmol/l
2.3
2.3
0.35
256
1474
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
416
2791
2.18
22.42
5.4
6.2
umol/l
8.5
10.9
12.92
389
2646
(3024561) Albumin [Mass/volume] in Serum or Plasma
343
2143
2.16
22.11
4.3
4.9
g/l
35.9
36.2
0.40
317
2016
(3018418) pH of Serum or Plasma
253
1426
2.20
20.95
3.7
4.0
ph
7.4
7.4
0.62
38
258
(3026008) Bacteria identified in Urine by Culture
254
1435
2.20
20.90
3.2
2.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
222
1210
2.21
19.80
6.5
3.4
kg/l
1.0
1.0
0.56
28
175
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
22
22
10.29
19.46
2.1
1.4
umol/l
93.7
92.8
0.00
13
12
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
547
4223
2.27
19.01
8.3
7.3
u/l
80.4
76.5
0.97
523
3973
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
255
1499
2.09
18.49
2.6
2.1
u/l
234.3
274.9
0.21
237
1417
(3021960) Folate [Moles/volume] in Serum or Plasma
204
1130
2.13
17.09
1.6
1.5
nmol/l
18.7
20.3
0.98
183
975
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
553
4385
2.17
16.48
5.9
3.8
pmol/l
14.4
14.5
0.94
525
4031
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
221
1291
2.03
15.87
2.2
2.0
mg/l
2.8
2.9
0.30
196
1106
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
188
1044
2.09
15.44
2.0
1.7
pmol/l
447.1
27514233.5
1.30
151
905
(3013650) Neutrophils [#/volume] in Blood by Automated count
437
3231
1.91
15.32
16.1
8.9
e9/l
4.3
4.0
1.50
384
2847
(3003396) Base excess in Arterial blood by calculation
116
534
2.40
15.04
6.2
9.6
mmol/l
2.3
1.0
2.75
97
429
(4010399)
90
370
2.64
14.80
1.5
1.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
389
2808
1.85
14.30
8.4
5.8
e9/l
0.0
0.0
0.54
342
2488
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
321
2192
1.85
14.04
2.5
2.2
nmol/l
72.0
74.3
0.74
299
2004
(3001604) Monocytes [#/volume] in Blood
387
2800
1.84
14.01
8.5
5.8
e9/l
0.6
0.6
0.55
340
2476
(21494755) Public health laboratory ask at order entry panel
13
785
0.15
13.77
1.2
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
398
2914
1.83
13.77
9.9
6.1
e9/l
0.2
0.2
0.83
354
2616
(3031040) Bacteria [#/volume] in Urine by Automated count
472
3647
1.87
13.66
6.1
3.9
e6/l
437.8
1527.5
0.53
17
56
(3019198) Lymphocytes [#/volume] in Blood
394
2891
1.81
13.38
8.4
5.8
e9/l
2.3
1.9
0.71
353
2604
(3023368) Bacteria identified in Blood by Culture
221
1362
1.90
13.18
4.5
4.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
413
3097
1.79
12.81
6.1
4.9
mmol/l
6.9
6.6
1.17
387
2849
(3020682) Albumin/Creatinine [Ratio] in Urine
234
1481
1.86
12.78
4.1
4.0
mg/mmol
8.4
9.8
0.15
146
954
(3019060) Gas panel - Arterial blood
72
292
2.63
12.13
5.8
6.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
222
1405
1.84
12.00
3.5
3.3
mg/l
326.9
339.3
0.01
148
914
(3014111) Lactate [Moles/volume] in Serum or Plasma
94
436
2.33
11.88
4.6
8.1
mmol/l
1.4
1.3
0.19
87
422
(3021447) Carbon dioxide [Partial pressure] in Venous blood
92
427
2.33
11.60
3.2
3.3
kpa
6.1
5.8
2.15
87
415
(3020191) Ethanol [Moles/volume] in Serum or Plasma
24
48
5.14
11.54
1.6
1.5
promille
1.0
1.3
0.45
17
37
(3037467) Urinalysis macro (dipstick) panel - Urine
487
3904
1.78
11.33
5.3
3.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
106
541
2.13
10.58
2.0
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
271
1886
1.71
10.23
4.1
3.4
e6/l
39.9
93.9
1.31
197
1299
(3024354) Oxygen [Partial pressure] in Venous blood
78
357
2.33
10.13
3.1
2.6
kpa
4.8
4.6
0.38
73
347
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
500
4097
1.74
10.13
5.1
3.0
u/l
50.2
46.4
0.63
467
3901
(3002032) Base excess in Venous blood by calculation
88
424
2.23
10.13
3.2
3.4
mmol/l
2.7
1.9
1.09
75
339
(3002582) Erythrocytes [#/volume] in Urine
235
1578
1.73
10.08
3.4
2.9
e6/l
67.6
103.8
0.29
183
1199
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
603
5242
1.98
9.88
7.1
4.5
mu/l
1.9
2.1
0.32
572
4862
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
268
1879
1.68
9.73
4.0
3.0
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
14
19
7.50
9.73
5.3
3.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
263
1838
1.68
9.65
7.1
5.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
218
1449
1.73
9.62
1.9
1.6
mmol/l
1.7
1.4
2.64
195
1241
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
18
694
0.24
9.58
1.1
1.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
173
1077
1.80
9.58
2.7
2.4
e6/l
6.1
6.4
0.08
153
952
(3020891) Body temperature
46
169
2.84
9.37
5.3
4.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
79
380
2.21
9.12
2.2
2.4
ug/l
3.5
7.9
3.89
67
344
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
68
307
2.34
9.11
1.8
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
101
535
2.03
9.09
1.9
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
413
0.18
9.05
1.5
1.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
47
178
2.76
9.05
1.4
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
138
816
1.86
8.98
2.7
3.6
mmol/l
0.8
0.8
0.16
126
771
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
198
1305
1.72
8.91
2.4
3.1
ng/l
1187.2
1110.6
0.08
161
1092
(3026782) Osmolality of Urine
160
995
1.78
8.82
2.7
2.6
mosm/kgh2o
518.9
567.8
1.81
134
850
(1761868) Lipid panel - Serum or Plasma
155
2343
0.57
8.81
3.3
2.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
140
837
1.84
8.78
2.3
2.9
mmol/l
2.4
2.4
0.48
117
733
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
272
1956
1.63
8.72
4.2
3.4
ng/l
30.4
46.9
0.66
180
1207
(40758558) Short blood count panel - Blood
202
1347
1.70
8.67
10.3
6.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
16
29
5.62
8.53
1.6
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
202
1354
1.69
8.48
1.3
1.2
u/ml
0.6
1.8
2.25
54
394
(3007853) Bacteria identified in Skin by Aerobe culture
115
654
1.90
8.41
1.9
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
210
1427
1.67
8.35
3.1
2.8
e6/l
0.2
0.5
2.07
158
1054
(3000494) Fungus identified in Specimen by Culture
113
641
1.91
8.33
1.7
1.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
111
626
1.92
8.32
4.8
5.8
mmol/l
1.0
1.0
0.93
100
589
(3011397) Hemoglobin [Presence] in Urine by Test strip
189
1250
1.70
8.32
5.4
3.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
130
774
1.83
8.23
1.8
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
462
3813
1.60
8.05
4.6
3.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
495
4161
1.62
7.93
4.5
3.8
mm/h
12.7
10.5
2.52
463
3884
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
131
791
1.80
7.90
2.1
1.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
51
219
2.43
7.65
3.0
3.2
mmol/l
25.1
24.1
1.37
40
201
(3035350) Ketones [Presence] in Urine by Test strip
355
2781
1.55
7.59
5.0
3.2
estimate
0.0
0.0
0.00
58
532
(3022096) Basophils/100 leukocytes in Blood
331
2554
1.55
7.57
8.4
5.9
%
0.6
0.7
2.11
306
2407
(3019069) Monocytes/100 leukocytes in Blood
341
2651
1.55
7.52
9.2
6.2
%
8.4
8.4
0.10
317
2514
(3029937) Albumin [Presence] in Urine by Test strip
213
1488
1.62
7.46
6.1
3.5
estimate
0.0
0.0
1.08
60
526
(36304419) Bacteria [Presence] in Urine
203
1406
1.62
7.35
3.1
2.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
489
0.21
7.32
1.1
1.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
338
2639
1.53
7.21
8.7
5.9
%
2.6
2.8
0.91
313
2482
(3002030) Lymphocytes/100 leukocytes in Blood
347
2737
1.52
6.99
8.8
5.9
%
29.1
28.2
0.87
320
2587
(3042936) Bacteria identified in Isolate by Culture
125
773
1.75
6.91
1.9
2.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
351
2783
1.52
6.85
6.2
4.5
estimate
0.0
0.0
0.50
62
538
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
89
498
1.90
6.81
2.4
2.5
u/l
27.5
130.6
0.55
73
424
(3009261) Glucose [Presence] in Urine by Test strip
354
2818
1.51
6.74
5.2
3.3
estimate
0.0
0.0
0.50
56
511
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
145
946
1.67
6.57
4.2
3.5
ng/l
209.2
534.0
1.01
95
678
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
148
972
1.66
6.54
2.7
2.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
578
5141
1.66
6.47
7.4
5.1
mmol/mol
40.9
39.2
2.77
530
4850
(3019550) Sodium [Moles/volume] in Serum or Plasma
635
5802
1.87
6.39
21.7
13.6
mmol/l
139.6
139.7
0.44
618
5653
(3023183) Ammonium ion [Moles/volume] in Plasma
30
108
2.86
6.39
1.6
3.9
umol/l
29.7
36.1
1.08
25
93
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
101
602
1.79
6.31
9.9
6.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
339
2704
1.48
6.22
8.7
5.8
%
57.2
57.1
0.05
314
2563
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
136
886
1.66
6.17
2.6
1.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
133
866
1.66
6.04
2.6
2.5
e6/l
1.6
1.0
1.34
73
474
(3014576) Chloride [Moles/volume] in Serum or Plasma
101
610
1.76
6.03
5.9
7.6
mmol/l
103.1
104.3
1.54
95
594
(3021901) Oxygen saturation in Capillary blood
25
84
3.05
6.01
2.6
2.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
124
794
1.68
6.00
2.2
2.3
umol/l
13.1
13.8
0.58
113
737
(40761535) Cells panel - Urine sediment
73
401
1.91
5.90
4.8
3.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
314
2490
1.47
5.81
12.9
8.8
e9/l
0.0
0.0
0.69
263
2066
(3023103) Potassium [Moles/volume] in Serum or Plasma
634
5826
1.81
5.76
21.7
13.7
mmol/l
4.0
4.0
0.07
617
5666
(3032080) INR in Blood by Coagulation assay
259
1981
1.48
5.74
7.7
7.7
inr
1.1
1.2
0.17
86
596
(3000991) Gas panel - Venous blood
72
398
1.90
5.72
5.8
9.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
81
467
1.83
5.64
2.3
2.4
g/l
0.2
0.2
0.22
70
439
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
66
356
1.94
5.64
3.3
3.6
pmol/l
4.5
4.6
0.54
60
313
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
29
112
2.66
5.45
1.9
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
189
1379
1.50
5.20
2.2
1.9
—
—
—
0
0
(3009343) pH of Capillary blood
58
308
1.96
5.19
3.8
3.1
ph
7.4
7.4
—
7
37
(3027945) Reticulocytes/100 erythrocytes in Blood
82
493
1.75
4.97
1.8
2.7
%
1.8
1.8
0.10
69
450
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
601
5503
1.59
4.81
6.0
4.0
mmol/l
6.2
5.8
5.87
558
5104
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
9
10
9.10
4.79
1.8
2.0
umol/l
10.9
19.2
—
9
10
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
275
2194
1.41
4.64
5.6
3.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
74
441
1.76
4.63
2.1
1.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
104
681
1.62
4.59
2.2
2.3
%
21.9
23.4
0.50
86
595
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
46
236
2.01
4.56
2.0
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
22
81
2.77
4.55
1.9
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
120
815
1.57
4.54
2.9
2.7
e6/l
6.4
2.4
1.59
58
424
(3004789) Transferrin [Mass/volume] in Serum or Plasma
111
741
1.59
4.52
2.2
2.2
g/l
2.4
2.4
0.11
94
692
(1616796) Gas panel - Central venous blood
25
99
2.58
4.51
4.2
2.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
33
150
2.26
4.44
2.0
2.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
54
296
1.89
4.43
3.9
3.2
mmol/l
1.4
1.5
0.12
41
219
(36660697) Celiac disease serology panel - Serum
75
464
1.69
4.12
1.2
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
182
1374
1.44
4.10
6.5
4.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
165
1223
1.45
4.10
1.4
1.4
g/l
2.0
2.4
2.16
83
794
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
63
375
1.75
3.98
3.3
3.7
mmol/l
1.2
1.2
0.26
51
327
(40767503) Oxygen content in Capillary blood by calculation
22
88
2.55
3.91
2.2
2.3
%
16.8
16.1
0.45
13
45
(3030981) Hyaline casts [#/volume] in Urine by Automated count
50
279
1.85
3.91
3.4
2.5
e6/l
0.1
0.2
0.37
50
270
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
87
568
1.61
3.89
2.3
1.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
21
476
0.42
3.87
1.7
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
61
364
1.74
3.83
1.4
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
110
763
1.52
3.78
2.0
2.4
ug/g
94.1
118.4
0.84
81
612
(3017509) Phencyclidine [Presence] in Urine
7
9
7.84
3.56
1.3
1.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
71
451
1.64
3.55
6.1
4.3
%
0.7
0.9
0.26
21
131
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
31
152
2.09
3.51
2.5
2.9
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
8
13
6.21
3.51
1.1
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
22
94
2.38
3.44
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
22
94
2.38
3.44
1.2
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
56
337
1.72
3.43
3.4
3.7
ng/l
81.9
78.7
0.12
47
306
(3024928) Oxygen saturation in Venous blood
23
101
2.32
3.39
2.2
2.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
24
108
2.26
3.35
1.2
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
17
65
2.65
3.32
1.7
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
23
102
2.30
3.32
5.3
2.8
mmol/l
3.7
2.4
0.54
16
66
(3021879) Hepatitis B virus core Ab [Presence] in Serum
76
502
1.58
3.25
1.6
1.5
—
—
—
0
0
(44813793)
12
38
3.19
3.22
1.1
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
66
423
1.62
3.20
6.2
4.5
%
0.1
0.1
0.07
17
116
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
92
638
1.51
3.17
1.9
2.7
umol/l
4.3
7.2
4.35
71
556
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
165
1280
1.38
3.10
1.9
1.6
mg/l
0.9
1.1
0.47
126
963
(3036481) Cortisol [Moles/volume] in Serum or Plasma
77
516
1.55
3.10
2.1
1.9
nmol/l
341.1
380.3
0.98
66
480
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
14
50
2.84
3.10
1.9
1.7
ug/l
18.5
20.2
0.12
14
50
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
45
263
1.76
3.07
7.9
12.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
53
325
1.68
3.06
2.3
2.1
u/l
10127.7
3065.6
0.60
17
137
(3025159) Blasts/100 leukocytes in Blood
62
398
1.61
3.00
6.4
4.5
%
0.0
0.2
1.03
11
100
(3001122) Ferritin [Mass/volume] in Serum or Plasma
310
2649
1.30
2.99
3.2
2.7
ug/l
101.4
111.7
0.40
283
2485
(3002179) Metamyelocytes/100 leukocytes in Blood
63
409
1.59
2.92
4.8
4.3
%
0.7
0.5
0.18
12
96
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
47
748
0.60
2.90
1.3
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
540
4986
1.34
2.87
25.3
14.9
%
13.8
13.6
2.38
530
4901
(3022621) pH of Urine by Test strip
56
356
1.62
2.83
4.7
2.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
56
361
1.60
2.68
1.3
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
108
802
1.41
2.62
1.4
1.3
titre
329.4
489.5
1.01
17
165
(3013512) EKG study
175
1406
1.32
2.59
4.3
3.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
121
2.02
2.58
1.4
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
17
75
2.30
2.52
1.5
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
43
264
1.67
2.51
1.9
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
54
352
1.58
2.49
1.9
2.9
e9/l
75.6
70.4
0.47
39
263
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
53
345
1.58
2.46
2.3
2.8
ng/l
195.1
168.8
0.19
46
306
(3033658) Prothrombin time (PT) actual/Normal
166
1335
1.32
2.43
4.8
3.7
%
91.7
92.9
0.23
159
1307
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
17
4.15
2.36
1.7
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
17
4.15
2.36
1.7
2.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
12
47
2.58
2.28
5.0
4.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
73
520
1.45
2.24
5.1
2.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
35
210
1.70
2.24
1.5
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
50
329
1.56
2.23
1.4
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
41
257
1.63
2.23
6.1
11.8
mmol/l
24.8
24.3
0.56
35
246
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
78
1055
0.71
2.21
2.6
2.8
ug/l
0.7
0.7
0.20
52
638
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
125
978
1.34
2.21
1.5
1.3
iu/ml
21.5
32.1
1.19
36
311
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
196
0.40
2.20
1.6
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
144
1151
1.31
2.19
1.8
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
25
137
1.85
2.16
2.4
4.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
121
946
1.34
2.15
1.4
1.3
u/ml
2.0
12.1
4.77
45
391
(3050129) First trimester maternal screen panel - Serum or Plasma
16
317
0.49
2.14
1.8
1.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
36
222
1.65
2.10
1.3
1.2
u/ml
0.9
1.9
—
5
16
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
124
1.88
2.09
1.1
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
76
554
1.42
2.07
15.2
19.7
inr
1.3
1.2
—
9
85
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
72
521
1.42
2.05
4.3
4.7
u/l
236.0
247.9
0.29
67
497
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
28
163
1.75
2.01
2.1
1.9
iu/l
2.7
5.4
—
7
59
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
17
84
2.05
1.97
1.6
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
51
2.38
1.96
1.6
1.9
—
—
—
0
0
(44790048)
14
64
2.21
1.95
1.8
1.8
—
—
—
0
0
(44806118)
14
64
2.21
1.95
1.8
1.8
—
—
—
0
0
(44790047)
14
64
2.21
1.95
1.8
1.8
—
—
—
0
0
(44790049)
14
64
2.21
1.95
1.8
1.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
58
2.26
1.91
1.2
1.3
nmol/l
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
39
252
1.58
1.91
2.9
3.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
278
0.49
1.90
1.4
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
22
121
1.84
1.90
1.7
1.8
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
13
264
0.48
1.89
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
13
264
0.48
1.89
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
13
263
0.48
1.87
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
13
263
0.48
1.87
1.3
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
22
122
1.83
1.86
1.7
1.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
40
2.52
1.84
1.1
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
10
40
2.52
1.84
1.4
1.6
%
13.2
10.6
—
10
40
(3028026) IgM [Mass/volume] in Serum or Plasma
50
346
1.48
1.81
1.4
1.7
g/l
1.2
1.5
0.73
42
319
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
13
60
2.19
1.78
1.2
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
36
233
1.57
1.77
4.5
3.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
47
323
1.49
1.77
1.1
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
95
1.92
1.76
1.6
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
95
741
1.33
1.73
1.6
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
527
5548
0.81
1.71
23.2
13.1
%
38.6
40.4
3.33
323
4362
(40768797) Stomach Pathology biopsy report
93
727
1.32
1.67
1.2
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
59
429
1.41
1.67
2.4
2.5
g/l
10.8
10.6
0.11
52
391
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
83
1.95
1.65
1.4
1.9
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
25
150
1.69
1.65
1.4
1.4
ug/g
301.5
306.2
0.04
14
84
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
61
452
1.38
1.56
1.3
1.2
iu/ml
157.7
155.8
0.01
24
172
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
44
2.29
1.53
1.6
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
44
2.29
1.53
1.6
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
44
2.29
1.53
1.6
1.8
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
12
58
2.09
1.50
1.4
1.5
pmol/l
649.6
414.7
—
5
47
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
58
2.09
1.50
1.6
1.8
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
21
124
1.71
1.48
5.5
4.0
mg/l
16.0
30.5
1.73
13
85
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
638
6176
1.32
1.46
13.9
9.4
u/l
28.7
27.4
0.89
622
6006
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
73
1.94
1.44
1.5
1.6
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
12
59
2.05
1.44
1.4
1.6
—
28.0
—
0
6
(3035880) pH of Pleural fluid
6
22
2.74
1.43
1.7
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
606
5831
1.26
1.43
19.9
12.4
mg/l
20.3
22.7
1.22
512
4552
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
9
178
0.50
1.41
1.6
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
155
1806
0.82
1.41
1.5
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
237
0.54
1.41
1.7
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
14
74
1.91
1.40
1.9
3.2
%
1.9
1.1
—
7
60
(3035933) Granulocytes/100 leukocytes in Blood
6
23
2.62
1.37
3.3
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
17
2.95
1.36
2.6
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
38
0.00
1.34
0.0
1.1
—
0.4
—
0
11
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
68
1.93
1.34
1.5
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
35
242
1.47
1.32
1.5
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
17
98
1.75
1.32
1.5
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
24
2.51
1.30
2.0
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
91
1.78
1.30
1.1
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
30
202
1.51
1.29
1.7
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
18
2.79
1.28
1.4
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
18
2.79
1.28
1.4
2.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
18
2.79
1.28
1.4
2.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
44
2.06
1.27
1.7
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
123
1.64
1.25
1.6
1.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
13
70
1.87
1.24
1.2
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
8
36
2.24
1.24
1.6
1.3
—
—
—
0
0
(4094501)
7
142
0.49
1.22
1.1
1.1
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
5
19
2.64
1.22
2.8
5.9
mmol/l
25.1
25.0
—
5
19
(3043238) Trisomy 21 risk [Likelihood] in Fetus
12
213
0.56
1.21
1.4
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
211
0.56
1.18
1.3
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
12
210
0.56
1.16
1.3
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
17
103
1.67
1.13
1.2
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
7
30
2.35
1.12
3.3
3.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
30
2.35
1.12
1.9
3.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
58
1.91
1.12
1.3
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
10
51
1.97
1.11
1.3
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
73
1.80
1.11
1.4
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
17
104
1.65
1.10
2.5
3.8
%
54.5
57.8
0.37
17
104
(4211845)
7
32
2.20
1.08
3.3
2.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
46
349
1.34
1.07
2.7
3.1
g/l
68.0
67.2
0.29
41
320
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
34
246
1.40
1.05
2.2
2.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
294
2704
1.15
1.04
4.1
4.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
171
1.48
1.03
1.2
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
5
22
2.28
1.03
1.0
2.1
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
9
47
1.93
1.02
1.9
2.0
—
45.4
—
0
5
(40768800) Prostate Pathology biopsy report
5
106
0.47
1.01
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
172
1.47
1.01
1.2
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
11
61
1.82
0.99
2.0
2.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
19
124
1.55
0.97
1.2
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
25
174
1.45
0.96
1.2
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
14
85
1.66
0.95
1.3
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
16
101
1.60
0.94
2.5
3.4
e9/l
3.7
4.3
0.45
16
101
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
134
1.51
0.92
1.6
2.3
ug/min
32.3
72.5
—
9
78
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
29
210
1.40
0.91
1.7
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
179
1610
1.15
0.86
4.2
2.9
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
15
97
1.56
0.82
1.1
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
47
1.71
0.81
1.4
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
44
349
1.28
0.79
1.3
1.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
11
66
1.68
0.79
1.1
1.3
mmol/l
68.8
63.0
—
5
58
(3019225) pH of Specimen
55
450
1.24
0.77
4.9
3.9
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
17
116
1.48
0.75
2.8
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
24
2.09
0.74
1.6
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
24
2.09
0.74
1.6
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
24
2.09
0.74
1.6
1.9
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
5
24
2.09
0.74
1.6
1.6
nmol/l
1.2
10.1
—
5
19
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
24
2.09
0.74
1.6
1.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
628
6147
1.18
0.74
18.9
11.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
106
0.56
0.73
1.0
1.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
92
1.53
0.72
4.1
3.4
—
3119.7
—
0
9
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
39
1.80
0.72
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
39
1.80
0.72
1.1
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
39
1.80
0.72
1.0
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
155
1398
1.14
0.72
2.6
2.6
umol/l
333.8
5572.0
4.43
140
1246
(3023419) Bacteria identified in Sputum by Culture
11
68
1.63
0.72
1.5
2.8
—
—
—
0
0
(3035941) MCH [Entitic mass]
647
6573
0.83
0.71
32.6
17.9
pg
30.1
30.3
0.98
637
6507
(3044640) Blood type and Crossmatch panel - Blood
192
1760
1.12
0.69
2.5
2.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
27
1.86
0.68
2.6
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
148
1338
1.13
0.67
2.4
2.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
647
6569
0.83
0.67
32.7
18.0
e9/l
259.7
253.0
1.70
633
6438
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
95
0.52
0.66
1.6
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
28
215
1.31
0.66
1.2
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
648
6577
0.84
0.65
33.0
18.0
e9/l
7.4
6.7
4.13
631
6431
(3000963) Hemoglobin [Mass/volume] in Blood
648
6577
0.84
0.65
32.9
18.1
g/l
134.8
136.8
2.97
639
6505
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
593
5793
1.14
0.65
5.4
4.4
mmol/l
2.7
2.8
1.95
546
5424
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
29
1.73
0.64
1.4
1.5
u/l
10.4
14.7
—
5
29
(3049717) Cytology report of Urine Cyto stain
24
181
1.34
0.64
2.2
2.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
648
6574
0.84
0.62
32.7
18.0
e12/l
4.5
4.5
1.38
631
6431
(3044941) Cell count panel - Synovial fluid
11
71
1.56
0.62
1.4
1.4
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
5
30
1.67
0.61
1.4
1.2
u/l
18.0
10.8
—
5
30
(3024731) MCV [Entitic volume]
648
6572
0.84
0.60
32.6
17.9
fl
90.6
90.6
0.07
638
6507
(3035637) Corticotropin [Mass/volume] in Plasma
8
51
1.57
0.60
1.9
1.4
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
20
0.00
0.60
0.0
1.7
—
6507.9
—
0
11
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
52
1.54
0.59
1.9
2.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
16
114
1.41
0.59
1.1
1.4
nmol/l
0.5
0.4
0.12
11
96
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7
114
0.61
0.58
1.0
1.1
—
8.6
—
0
8
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
98
1.44
0.57
2.3
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
55
1.46
0.56
2.0
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
55
1.46
0.56
1.0
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
23
178
1.30
0.53
1.3
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
24
187
1.29
0.53
3.5
3.9
g/l
0.4
0.3
0.15
11
87
(21494434) Karyotype in Bone marrow
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
133
0.67
0.52
1.7
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
133
0.67
0.52
1.7
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
583
5710
1.12
0.52
5.0
4.0
mmol/l
4.5
4.7
3.51
540
5386
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
166
1789
0.91
0.51
4.1
4.5
ug/l
2.8
2.3
0.25
145
1612
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
75
1.47
0.51
1.1
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
45
1.56
0.49
1.0
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
45
1.56
0.49
2.1
1.2
—
—
—
0
0
(4035726)
36
430
0.83
0.48
1.5
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
11
76
1.45
0.48
1.4
2.7
u/ml
23.9
3.9
0.47
11
68
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
132
1433
0.90
0.47
4.1
3.9
%
20.4
21.0
0.16
57
632
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
138
1272
1.11
0.47
1.8
1.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
49
1.43
0.46
1.1
2.2
pg
32.6
33.6
—
7
49
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
49
1.43
0.46
1.0
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
559
5475
1.10
0.45
4.3
3.6
mmol/l
1.5
1.3
8.77
502
5119
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
51
1.38
0.44
1.3
1.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
25
202
1.25
0.44
5.1
3.6
mmol/l
24.2
25.0
0.67
25
191
(3023323) Follitropin [Units/volume] in Serum or Plasma
40
341
1.18
0.43
1.4
1.3
iu/l
15.6
26.6
1.77
33
292
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
93
0.64
0.42
1.3
1.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
5
32
1.57
0.42
1.4
1.3
ug/l
5.9
6.6
—
5
25
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
10
139
0.72
0.42
8.2
2.9
mg/l
1.8
1.5
—
10
127
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
15
0.00
0.41
0.0
1.6
—
15.8
—
0
10
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(4034850)
23
186
1.24
0.41
11.0
9.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
1.0
—
0
10
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
35
1.43
0.39
2.2
1.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
35
1.43
0.39
2.0
2.5
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
16
203
0.78
0.38
1.7
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
55
487
1.14
0.38
4.9
3.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
18
143
1.27
0.37
1.5
1.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
37
1.35
0.37
1.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
167
0.77
0.34
1.4
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
73
1.38
0.34
1.1
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
73
1.38
0.34
1.1
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
45
1.34
0.34
1.2
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
45
1.34
0.34
2.2
2.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
33
284
1.17
0.33
1.6
2.9
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
46
407
1.14
0.33
10.8
2.8
e9/l
3.9
4.1
0.37
35
340
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
74
1.36
0.32
1.1
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
75
1.34
0.30
1.1
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
577
5690
1.07
0.30
4.8
4.0
mmol/l
1.3
1.4
10.78
530
5340
(3045414) Leukocytes [Presence] in Urine
28
241
1.17
0.29
2.2
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
161
0.80
0.27
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
67
1.20
0.26
1.1
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
22
256
0.85
0.26
2.3
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
420
4286
0.95
0.25
3.5
3.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
74
1.22
0.25
1.1
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
75
1.20
0.25
1.2
1.9
—
—
—
0
0
(4268621)
9
76
1.19
0.24
2.8
2.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
77
1.17
0.24
1.4
1.2
—
—
—
0
0
(4024509)
5
39
1.28
0.23
3.8
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
94
0.74
0.22
1.1
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
16
135
1.19
0.21
1.3
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
42
1.19
0.21
1.6
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.3
—
1.8
—
0
10
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
0.2
—
0
5
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
49
1.23
0.20
1.5
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
49
1.23
0.20
1.5
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
49
1.23
0.20
1.5
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
50
1.20
0.19
1.5
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
50
1.20
0.19
1.5
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
50
1.20
0.19
1.5
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
19
218
0.87
0.19
1.4
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
11
90
1.23
0.19
1.7
5.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
17
196
0.86
0.19
1.6
1.6
nmol/l
37.0
39.6
0.20
17
188
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
58
1.21
0.18
2.0
3.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
131
0.84
0.17
1.5
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
69
1.16
0.16
1.5
2.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
14
120
1.17
0.16
1.1
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
79
1.14
0.15
1.4
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
108
1038
1.05
0.15
1.7
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
218
2233
0.97
0.15
2.0
2.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
93
1.19
0.14
1.5
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
22
198
1.11
0.14
2.5
1.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
98
0.81
0.13
1.3
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
548
5436
1.04
0.13
16.7
10.9
ml/min/173m2
90.2
86.7
3.15
436
4434
(3003338) MCHC [Mass/volume]
511
5155
0.97
0.12
29.3
15.6
g/l
332.5
333.4
1.17
506
5128
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
20
182
1.10
0.11
1.9
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
45
426
1.06
0.11
2.1
2.5
ml/min/173m2
72.6
73.1
0.02
11
166
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
134
1.12
0.11
2.8
2.6
u/ml
0.4
0.3
—
10
69
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
10
115
0.87
0.10
1.2
3.5
g/l
0.0
0.0
—
10
110
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
67
643
1.05
0.10
4.6
4.0
%
27.9
31.4
2.12
55
454
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
11
125
0.88
0.10
1.5
1.2
u/ml
234.0
255.4
—
6
77
(3006442) Creatine [Moles/volume] in Serum or Plasma
5
44
1.14
0.10
3.6
1.5
—
69.6
—
0
5
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
46
1.09
0.09
1.2
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
10
87
1.15
0.09
1.8
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
11
124
0.89
0.09
1.2
1.1
u/ml
7.2
2.2
—
6
52
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
56
1.07
0.08
1.0
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
56
1.07
0.08
1.2
1.8
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
164
0.91
0.08
1.3
2.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
84
1.07
0.07
2.9
2.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
86
839
1.03
0.06
2.0
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
102
0.88
0.06
1.6
1.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
119
1.09
0.06
1.5
1.4
—
—
—
0
0
(1002224) Polysomnography panel
30
287
1.05
0.05
1.1
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
27
259
1.04
0.04
1.2
1.3
miu/ml
237.0
243.8
—
5
130
(3002256) Pathology report gross observation
70
688
1.02
0.03
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
26
269
0.97
0.02
1.1
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
47
462
1.02
0.01
2.3
4.3
ug/l
25.9
36.8
0.15
38
379
(3008401) Mugwort IgE Ab [Units/volume] in Serum
11
104
1.06
0.01
1.0
1.1
u/ml
0.2
2.4
—
6
44
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
135
1.04
0.00
1.2
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
18
185
0.97
0.00
1.4
2.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
97
1.03
0.00
1.4
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
14
137
1.02
0.00
1.4
1.7
pmol/l
142.6
215.7
1.69
14
129
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
108
1.02
0.00
2.2
1.5
—
—
—
0
0
(3000492) Spirometry study
62
624
0.99
0.00
1.5
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
63
627
1.01
0.00
1.4
1.3
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
187.3
—
0
6
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
8
80
1.00
0.00
2.8
2.0
—
1744.0
—
0
5
(3022475) Manganese [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
6
0.00
0.00
0.0
2.5
—
7.4
—
0
6
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
0
6
0.00
0.00
0.0
7.7
—
22.2
—
0
6
(40758047) Lysozyme [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
7.6
—
0
6
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
11
110
1.00
0.00
1.0
1.1
u/ml
2.7
6.4
—
6
60
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
6.9
—
0
9
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
3.7
—
0
5
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(4038314)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
89
1.01
0.00
5.2
2.6
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
63
0.95
0.00
1.3
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
54
0.93
0.00
1.2
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
7.0
—
0.2
—
0
5
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4062490)
5
50
1.00
0.00
1.2
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
64
0.94
0.00
1.5
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
60
1.00
0.00
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
87
0.92
0.00
1.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
81
0.99
0.00
1.3
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(4306422)
9
93
0.97
0.00
1.8
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
8
0.00
0.00
0.0
1.9
—
0.5
—
0
8
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_PARAPER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_PARAPER | 2.537 [2.08, 3.1] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.203 |
During the follow-up period (1.1.1998 — 31.12.2019), 288 out of 2042 females with F5_PARAPER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_PARAPER | 2.627 [2.24, 3.08] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 327 out of 1874 males with F5_PARAPER died.
Mortality risk
Mortality risk for people of age
years, who have F5_PARAPER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.253% | 0.544% |
| 5 | 1.424% | 2.944% |
| 10 | 3.508% | 7.344% |
| 15 | 6.708% | 14.115% |
| 20 | 12.293% | 22.698% |
Relationships between endpoints
↥Index endpoint: F5_PARAPER – Paranoid personality disorder
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data